1. View from 209 km above 58°10'N 17°10'E Experience from building The Medicon Valley biotech cluster by Bent Christensen Managing Director Medicon Valley Academy Sunrise Valley, Vilnius, 28 november 2002

2. Know more ??? Klick on Lessons learned

3. Sunrise Valley, Vilnius 28 november 2002 A clear vision from the very beginning -networking is a fragmented striving towards a common goal by independent partners. The network-glue is the vision and the values shared by everybody

4. Sunrise Valley, Vilnius 28 november 2002 Know yourself !! Mapping is esentiel (and if possible benchmarking) Mandatory to know own strengths and weaknesses and opportunities and threaths in the surroundings Repeat mapping as appropriate

5. Sunrise Valley, Vilnius 28 november 2002 Know your stakeholders -and be relevant

6. Sunrise Valley, Vilnius 28 november 2002 What makes us relevant to our stakeholders ? What do these stakeholders need or expect from our organization? How well does our organization perform against those expectations ? What do these stakeholders want us to do more of or less of? What additional or increased programs or services do they think we should be offering if resources were available?

7. Sunrise Valley, Vilnius 28 november 2002 What shall we do on strategic level to make our vision come through: -the mission ?

8. Sunrise Valley, Vilnius 28 november 2002 Mission: In a knowledge based cluster key abilities and capabilities are: -creation of knowledge on excellence level -protection og intellectual property rights -transfer of knowledge and technologies -exploitation of transferred knowledge

9. Sunrise Valley, Vilnius 28 november 2002 Excellence Break throughs are unpredictable Will to prioritize is mandatory Exploit your strengths Nobody asks for number two

10. Sunrise Valley, Vilnius 28 november 2002 Transfer Protect the intellectual property rights Efficient information academia/enterprises Tech-transfer office(s)

11. In: Knowledge & ideas products Patent protected period 20 years Drug development timePatent protected sale 12-14 years The drug development pipe-line 6-8 years Investor-risk-profile 10 Number of drug candidates In pipe-line 1 Laboratory researchClinical tests Why patenting is important. Sunrise Valley, Vilnius 28 november 2002

12. Exploitation Positive conditions for entrepreneurs -legislation -investors -taxes -scinence parks/incubators -accept failures

13. Sunrise Valley, Vilnius 28 november 2002 Important to discuss impact of biotechnology on society -ethics -environment -public acceptance i.e. in Denmark 70% of population expresses scepticism to biotechnology

14. Sunrise Valley, Vilnius 28 november 2002 Get known -brand -inform -exhibit -address -be present -be visible -invite -join networks

15. Sunrise Valley, Vilnius 28 november 2002 TRANSFER Political and strategic Ligthhouses in The Knowledge Society Closing the circle EXPLOIT CREATE